Revolution Medicines to Present New Preclinical Data from RAS(ON) Inhibitor Programs at AACR-NCI-EORTC Virtual International Conference on Molecular Targets and Cancer Therapeutics

On September 30, 2021 Revolution Medicines, Inc. (Nasdaq: RVMD), a clinical-stage precision oncology company focused on developing targeted drugs to inhibit frontier targets that drive and sustain RAS-addicted cancers, reported that new preclinical data from several of the company’s RAS(ON) inhibitor programs will be reported in an invited oral presentation during a plenary session of the upcoming AACR (Free AACR Whitepaper)-NCI-EORTC Virtual AACR-NCI-EORTC (Free AACR-NCI-EORTC Whitepaper) International Conference on Molecular Targets and Cancer Therapeutics (EORTC-NCI-AACR) (Free ASGCT Whitepaper) (Free EORTC-NCI-AACR Whitepaper) being held October 7-10, 2021 (Press release, Revolution Medicines, SEP 30, 2021, View Source [SID1234590575]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Details of the upcoming oral presentation at the AACR (Free AACR Whitepaper)-NCI-EORTC conference are as follows:

Title: Discovery and Development of RAS(ON) Inhibitors Beyond KRASG12C

Presenter: Steve Kelsey, M.D., president, research and development

Session: Plenary Session 5: Drugging Difficult Targets

Session Date/Time: Saturday, October 9, 2021, 12:05 – 1:55 p.m. Eastern

Session Panel Discussion: To follow completion of Plenary Session 5 presentations
To access a copy of the presentation slides, please visit the "Events & Presentations" page of Revolution Medicines’ website at View Source The presentation slides will be available on the "Events & Presentations" page of the Revolution Medicines website for at least 14 days following the conference.

Additional information on the AACR (Free AACR Whitepaper)-NCI-EORTC Virtual International Conference on Molecular Targets and Cancer Therapeutic is available through the conference website at View Source